Legend Biotech Corporation
LEGN
$35.46
-$0.17-0.48%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 967.56M | 1.01B | 1.12B | 1.21B | 1.29B |
| Total Receivables | 228.99M | 166.85M | 124.89M | 103.98M | 101.38M |
| Inventory | 35.59M | 30.93M | 23.90M | 23.55M | 18.87M |
| Prepaid Expenses | 17.67M | 15.56M | 12.37M | 9.53M | 12.32M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 70.00K | 70.00K | 70.00K | 583.00K | 431.00K |
| Total Current Assets | 1.25B | 1.22B | 1.28B | 1.35B | 1.42B |
|
|
|||||
| Total Current Assets | 1.25B | 1.22B | 1.28B | 1.35B | 1.42B |
| Net Property, Plant & Equipment | 233.60M | 206.03M | 201.22M | 203.48M | 219.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.14M | 2.08M | 2.16M | 2.51M | 2.77M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 204.31M | 188.74M | 178.49M | 175.29M | 146.44M |
| Total Assets | 1.69B | 1.62B | 1.67B | 1.74B | 1.80B |
|
|
|||||
| Total Accounts Payable | 75.36M | 58.14M | 38.59M | 26.91M | 39.49M |
| Total Accrued Expenses | -- | 57.82M | 64.51M | 141.22M | 132.50M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.91M | 5.34M | 4.79M | 4.34M | 3.33M |
| Total Finance Division Other Current Liabilities | 184.22M | 113.07M | 169.75M | 98.43M | 118.99M |
| Total Other Current Liabilities | 184.22M | 113.07M | 169.75M | 98.43M | 118.99M |
| Total Current Liabilities | 265.48M | 234.37M | 277.65M | 270.89M | 294.30M |
|
|
|||||
| Total Current Liabilities | 265.48M | 234.37M | 277.65M | 270.89M | 294.30M |
| Long-Term Debt | 310.26M | 305.75M | 301.20M | 296.62M | 291.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 71.74M | 51.72M | 44.61M | 45.63M | 44.04M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.89M | 6.06M | 6.15M | 6.58M | 9.28M |
| Total Liabilities | 654.38M | 597.90M | 629.61M | 619.72M | 639.18M |
|
|
|||||
| Common Stock & APIC | 2.73B | 2.71B | 2.70B | 2.69B | 2.68B |
| Retained Earnings | -1.89B | -1.76B | -1.66B | -1.69B | -1.56B |
| Treasury Stock & Other | 189.14M | 67.52M | 6.27M | 118.36M | 46.45M |
| Total Common Equity | 1.04B | 1.02B | 1.04B | 1.12B | 1.16B |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.04B | 1.02B | 1.04B | 1.12B | 1.16B |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.04B | 1.02B | 1.04B | 1.12B | 1.16B |
|
|
|||||